Know Cancer

or
forgot password
  • cancer clinical trials in joliet, IL

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Joliet Oncology-Hematology Associates, Limited - West

    Trial Locations
    Joliet Oncology-Hematology Associates, Limited - West
    Midwest Center for Hematology/Oncology
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Joliet Oncology-Hematology Associates, Limited - West

    Trial Locations
    Joliet Oncology-Hematology Associates, Limited - West
    Midwest Center for Hematology/Oncology
    Lymphoma
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Lymphoma
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Joliet Oncology-Hematology Associates, Limited - West

    Trial Locations
    Joliet Oncology-Hematology Associates, Limited - West
    Midwest Center for Hematology/Oncology
    Lung Cancer
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Joliet Oncology-Hematology Associates, Limited - West

    Trial Locations
    Joliet Oncology-Hematology Associates, Limited - West
    Midwest Center for Hematology/Oncology
    Esophageal Cancer, Gastric Cancer
    Anastrozole & ZD1839 Compared With Fulvestrant & ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Breast Cancer
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Lung Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Saint Joseph Medical Center
    Joliet, Illinois 60435
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Joliet Oncology Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Kidney Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Recurrent Mantle Cell Lymphoma
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Joliet Hematology Associates
    Joliet, Illinois 60435
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Midwest Center for Hematology/Oncology
    Joliet, Illinois 60432
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer